Glucose-sensing glucagon-like peptide-1 receptor neurons in the dorsomedial hypothalamus regulate glucose metabolism
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide-1 (GLP-1) regulates energy homeostasis via activation of the GLP-1 receptors (GLP-1Rs) in the central nervous system. However, the mechanism by which the central GLP-1 signal controls blood glucose levels, especially in different nutrient states, remains unclear. Here, we defined a population of glucose-sensing GLP-1R neurons in the dorsomedial hypothalamic nucleus (DMH), by which endogenous GLP-1 decreases glucose levels via the cross-talk between the hypothalamus and pancreas. Specifically, we illustrated the sufficiency and necessity of DMH GLP-1R in glucose regulation. The activation of the DMH GLP-1R neurons is mediated by a cAMP-PKA–dependent inhibition of a delayed rectifier potassium current. We also dissected a descending control of DMH GLP-1R –dorsal motor nucleus of the vagus nerve (DMV)–pancreas activity that can regulate glucose levels by increasing insulin release. Thus, our results illustrate how central GLP-1 action in the DMH can induce a nutrient state–dependent reduction in blood glucose level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1. Exogenous GLP-1 decreases blood glucose level in the DMH. (A) Experimental paradigm for ICV injection GLP-1R agonist Exn4 experiment in WT mice. (B) ICV Exn4 caused decrease in fasting blood glucose. *P < 0.05 and ***P < 0.001 (t test). (C) To investigate DMH GLP-1R neuron response to Exn4 injection, we injected adeno-associated virus (AAV)–DIO–mCherry in the DMH of GLP-1R-Cre mice and stained with c-Fos antibody. The representative images showed that ICV Exn4 did increase c-Fos expression in GLP-1R neurons within the DMH. (D) Quantification of c-Fos–positive cell ration (relative to total GLP-1R neurons). ***P < 0.001 (t test). (E) Experimental paradigm for Exn4 injection in DMH of WT mice. (F) Fasting blood glucose decreased after Exn4 injection, an effect that was antagonized by the cAMP-PKA blocker, cAMP-Rp. *P < 0.05, **P < 0.01, and ***P < 0.001 [analysis of variance (ANOVA)], vehicle versus Exn4; #P < 0.05 (ANOVA), Exn4 versus Exn4 + cAMP-Rp (ANOVA). Numbers of animals are indicated in each panel.](https://figures.cochat.ai/paper-figures/e4e7ef7ae0eb4252a0ac638401001932/glucose-sensing-glucagon-like-peptide-1-receptor-neurons-in-the-dorsomedial-figure-1.jpg)






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The DMH plays a pivotal role in long-term metabolic regulation, including energy expenditure, thermogenesis, and circadian rhythm (27–29).”
From GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans (2024) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371 · cited 2×
“Habener, Glucagonlike peptide I (7-37) actions on endocrine pancreas.”
BackgroundMechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Drucker, D. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.001 · Cited by 2,170 · cited 1×
“One important advantage of GLP-1–based therapies for diabetes is that GLP-1–induced insulin release is dependent on circulating glucose levels, making GLP-1–based therapies less likely than other insulin secretagogues to cause hypoglycemia (3, 4).”
BackgroundGlucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Self-citationChannelrhodopsin-2-assisted circuit mapping of long-range callosal projections
Petreanu, L., Huber, D., Sobczyk, A., & Svoboda, K. (2007) · Nature Neuroscience · doi:10.1038/nn1891 · Cited by 930 · cited 3×
“Habener, Glucagonlike peptide I (7-37) actions on endocrine pancreas.”
BackgroundMethodPyke, C., Heller, R. S., Kirk, R. K., Ørskov, C., Reedtz-Runge, S., Kaastrup, P., Hvelplund, A., Bardram, L., Calatayud, D., & Knudsen, L. B. (2014) · Endocrinology · doi:10.1210/en.2013-1934 · Cited by 876
Larsen, P. J., Tang-Christensen, M., Holst, J. J., & Ørskov, C. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00434-4 · Cited by 663
An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger
Krashes, M. J., Shah, B. P., Madara, J. C., Olson, D. P., Strochlic, D. E., Garfield, A. S., Vong, L., Pei, H., Watabe-Uchida, M., Uchida, N., et al. (2014) · Nature · doi:10.1038/nature12956 · Cited by 603
Exon duplication and divergence in the human preproglucagon gene
Bell, G. I., Sanchez-Pescador, R., Laybourn, P. J., & Najarian, R. C. (1983) · Nature · doi:10.1038/304368a0 · Cited by 593
Cork, S. C., Richards, J. E., Holt, M. K., Gribble, F. M., Reimann, F., & Trapp, S. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.07.008 · Cited by 478
Discovery, characterization, and clinical development of the glucagon-like peptides
Drucker, D. J., Habener, J. F., & Holst, J. J. (2017) · Journal of Clinical Investigation · doi:10.1172/jci97233 · Cited by 418 · cited 1×
“One important advantage of GLP-1–based therapies for diabetes is that GLP-1–induced insulin release is dependent on circulating glucose levels, making GLP-1–based therapies less likely than other insulin secretagogues to cause hypoglycemia (3, 4).”
Background
Cited by
GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans
Kim, K. S., Park, J. S., Hwang, E., Park, M. J., Shin, H. Y., Lee, Y. H., Kim, K. M., Gautron, L., Godschall, E., Portillo, B., et al. (2024) · Science · doi:10.1126/science.adj2537 · Cited by 148
Singh, I., Wang, L., Xia, B., Liu, J., Tahiri, A., El Ouaamari, A., Wheeler, M. B., & Pang, Z. P. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00914-3 · Cited by 98
“The morphological analysis of the axonal terminals revealed dense GLP-1 neuronal terminals in the hypothalamus, especially in the PVN, DMH, ARC, and the medial vestibular parvicellular subfields nucleus (MvePC) (Fig.”
BackgroundResultSelf-citationBlood‐Glucose‐Powered Metabolic Fuel Cell for Self‐Sufficient Bioelectronics
Maity, D., Ray, P. G., Buchmann, P., Mansouri, M., & Fussenegger, M. (2023) · Advanced Materials · doi:10.1002/adma.202300890 · Cited by 71
GLP-1 programs the neurovascular landscape
Chen, B., Yu, X., HORVATH-DIANO, C., Ortuño, M. J., Tschöp, M. H., Jastreboff, A. M., & Schneeberger, M. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.09.003 · Cited by 62
Liu, L., Huang, Z., Zhang, J., Wang, M., Yue, T., Wang, W., Wu, Y., Zhang, Z., Xiong, W., Wang, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52815-3 · Cited by 58
Self-citationChen, Z., Deng, X., Shi, C., Jing, H., Tian, Y., Zhong, J., Chen, G., Xu, Y., Luo, Y., & Zhu, Y. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178239 · Cited by 48
“Considering prior evidence that GLP-1R activation augments glucose tolerance (44, 45), we probed the potential of LS GLP-1R neurons to modulate glucose homeostasis.”
Park, J. S., Kim, K. S., & Choi, H. J. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0106 · Cited by 60
“Direct injection of exendin-4 to the DMH reduced blood glucose levels, while liraglutide injection into the DMH did not alter 24-hour food intake or body weight [70,71].”
Chen, Z., Liu, X., & Kenny, P. J. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106860 · Cited by 49
Butterflies in the gut: the interplay between intestinal microbiota and stress
Lai, T.-T., Liou, C.-W., Tsai, Y.-H., Lin, Y.-Y., & Wu, W. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00984-6 · Cited by 29
“Tracing studies confirm that preproglucagon neurons in NTS project to the PVN [146–149].”
BackgroundGLP-1 physiology and pharmacology along the gut-brain axis
Beutler, L. R. (2026) · Journal of Clinical Investigation · doi:10.1172/jci194744 · Cited by 35
“Additional studies confirmed that virus-mediated GLP-1R knockdown in rats and mice increased bodyweight, but found this occurred through decreased energy expenditure, not increased food intake (111, 112).”
DPP-IV as a potential candidate in anti-obesity and obesity-related diseases treatment
Guo, X., Feng, H., Cai, L., Zheng, J., & Li, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117464 · Cited by 22
Xia, M., Li, C., Zhang, Y., Wang, T., Zhang, C., Zhou, J., Zhu, X., Hong, H., Li, H., Qian, Z., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103857 · Cited by 23
“It plays a significant role in glucose homeostasis regulation, insulin secretion, and various metabolic processes [72].”
Self-citationChanges of Signaling Pathways in Hypothalamic Neurons with Aging
Masliukov, P. M. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45100523 · Cited by 20
“GLP-1R GLP-Figure GLP-1R agonists can inhibit eating through activation of vagal afferent GLP-1Rs and via a direct effect on the brain [28].”
BackgroundIdentification of a GABAergic neural circuit governing leptin signaling deficiency-induced obesity
Han, Y., He, Y., Harris, L., Xu, Y., & Wu, Q. (2023) · eLife · doi:10.7554/elife.82649 · Cited by 18
Challenges in Adapting Fibre Optic Sensors for Biomedical Applications
Karimian, S., Ali, M. M., McAfee, M., Saleem, W., Duraibabu, D. B., Memon, S. F., & Lewis, E. (2025) · Biosensors · doi:10.3390/bios15050312 · Cited by 18
Spezani, R., Marinho, T. D. S., Santos-Reis, T., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2023) · Peptides · doi:10.1016/j.peptides.2023.171138 · Cited by 17
GLP-1, GIP, and Glucagon Agonists for Obesity Treatment: A Hunger Perspective
d’Ávila, M., Hall, S., & Horváth, T. L. (2024) · Endocrinology · doi:10.1210/endocr/bqae128 · Cited by 14
Distinct Roles for Brain and Pancreas in Basal and Postprandial Glucose Homeostasis
Alonge, K. M., Porte, D., & Schwartz, M. W. (2023) · Diabetes · doi:10.2337/db22-0969 · Cited by 16
Abu-Nejim, H., & Becker, R. C. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01350-7 · Cited by 16
“…oxidation leads to liver fat reduction and liver Neuro-humoral actions include modulation of hypo-thalamic appetite centers, leading to increased satiety and reduced caloric intake, as well as slowing of gastric emptying, which further contributes to appetite suppression and glycemic control [74].”
Yin, K., Zhang, T., Lu, X., Shen, Q. X., Gu, K., Huang, Y., Li, C., Hou, J., Li, J., & Zhang, G. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114983 · Cited by 15
Zhang, Z., Yan, Q., Wu, W., Zhao, Y., Zhang, H., & Li, J. (2023) · Journal of International Medical Research · doi:10.1177/03000605231177191 · Cited by 12
“GLP-1 can also reduce food intake by enhancing satiety through central mechanisms in the hypothalamus and brainstem.(53) In addition, the effects of GLP-1RA on improving hepatic lipotoxicity have been demonstrated in animal and human studies.”
BackgroundHaspula, D., & Cui, Z. (2023) · Cells · doi:10.3390/cells12131801 · Cited by 14
Central and peripheral neural circuits regulating glucose homeostasis
Espinoza, D., Seibold, F., & Stanley, S. A. (2025) · npj Biomedical Innovations. · doi:10.1038/s44385-025-00036-8 · Cited by 17
“Like other hypothalamic regions, neurons in the DMH express various neuropeptides including corticotropin releasing factor (CRF), NPY and cholecystokinin (CCK) as well as receptors such as MC4R, leptin receptors, and CCK-1 receptors 39 – 41 .”
InfluentialA critical review of ethanol effects on neuronal firing: A metabolic perspective
Popova, D., Sun, J. K., Chow, H., & Hart, R. P. (2024) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15266 · Cited by 15
Hypothalamus and brainstem circuits in the regulation of glucose homeostasis
Lin, Z., Xuan, Y., Zhang, Y., Zhou, Q., & Qiu, W. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00474.2024 · Cited by 16
GLP-1R in diabetes mellitus: from basic discovery to therapeutics development
Li, S., Huang, N., Wang, M., Huang, W., Luo, Y., & Huang, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1610512 · Cited by 21
“It has recently been shown that GLP-1R neurons in the dorsomedial hypothalamic nucleus regulate pancreatic activity by affecting the dorsal motor nucleus of the vagus, speci fi cally lowering blood glucose levels by increasing insulin release (Huang et al., 2022).”
Glucagon-Like Peptide 1 (GLP-1) Action on Hypothalamic Feeding Circuits
Hwang, E., Portillo, B., & Williams, K. W. (2025) · Endocrinology · doi:10.1210/endocr/bqaf125 · Cited by 10
Body temperature regulates glucose metabolism and torpid behavior
Lee, M., Chang, C.-P., Toda, C., Nemoto, T., & Enoki, R. (2025) · Nature Communications · doi:10.1038/s41467-025-61499-2 · Cited by 14
“The brain particularly hypothalamic nuclei such as the ARC, ventromedial hypothalamus (VMH), dorsomedial hypothalamus (DMH),andPVN playacriticalrole in sensing blood glucose, which can re fl ect energy levels to regulate whole-body energy metabolism 10,31,32 .”
Lasher, A. T., Srivastava, H. K., & Sun, L. Y. (2022) · Biomedicines · doi:10.3390/biomedicines10081907 · Cited by 10
“It has recently been reported that central nervous system GLP-1 signaling can influence whole body glucose homeostasis and energy expenditure via a mechanism involving cross talk between the hypothalamus and pancreas [44], demonstrating that proglucagon-derived peptides can influence metabolism both centrally and peri…”
BackgroundThe unexpected role of GIP in transforming obesity treatment
Zandvakili, I., & Pérez–Tilve, D. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.07.022 · Cited by 9
Yang, S., Tang, Q., Zhang, Y., Du, Y., Zhao, X., Mei, F., & Li, Y. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110090 · Cited by 6
Role of hypothalamus function in metabolic diseases and its potential mechanisms
Zhang, X., Yang, J., Li, Y., Li, Y., & Li, G. (2025) · PeerJ · doi:10.7717/peerj.19532 · Cited by 11
“First, in glucose metabolism, fl uctuations in blood glucose levels directly trigger the hypothalamic response mechanism ( Huang et al., 2022 ).”
Brain Defense of Glycemia in Health and Diabetes
Mirzadeh, Z., & Faber, C. L. (2024) · Diabetes · doi:10.2337/dbi24-0001 · Cited by 9
Wu, W., Zheng, J., Wang, R., & Wang, Y. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115863 · Cited by 9
Stanley, S. A. (2025) · Diabetes · doi:10.2337/dbi24-0051 · Cited by 11
“Targeted activation of both GLP-1R-expressing neurons in the DMH and of GLP-1R projections from the DMH to the parasympathetic DMV lowered blood glucose via increased insulin release in mice (59).”
Glucose-sensitive hypothalamic nuclei traced through functional magnetic resonance imaging
Manuel, J., Halbe, E., Ewald, A. C., Hoff, A., Jordan, J., Tank, J., Heusser, K., & Gerlach, D. A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1297197 · Cited by 7
“…of new technologies such as optogenetics or chemogenetics resulted in rapid advances in knowledge of hypothalamic metabolic control in animals (Huang et al., 2022), the hypothalamus has been a difficult region to study in humans due to its small size, location deep within the brain, and its…”
Sanetra, A. M., Palus‐Chramiec, K., Chrobok, Ł., Jeczmien‐Lazur, J. S., Gawron, E., Klich, J. D., Pradel, K., & Lewandowski, M. H. (2022) · Nutrients · doi:10.3390/nu14235034 · Cited by 8
The therapeutic potential of early exercise in Alzheimer's disease: Focus on the brain-spleen axis
Wang, T., Feng, L., & Tian, Z. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102980 · Cited by 6
Gallardo, N., Artigas-Jerónimo, S., Mazuecos, L., & Andrés, A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1731725 · Cited by 11
“Recent studies identi fi ed glucose-sensing GLP-1R neurons in the DMH that lower blood glucose by enhancing vagal output to the pancreas through cAMP – PKA signaling (39).”
Wimer, L. A., Kaneshiro, K. R., Ramirez, J., Bose, N., Valdearcos, M., Shanmugam, M. M., Farrera, D. O., Singh, P. P., Beck, J., Sellegounder, D., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116422 · Cited by 6
“31,32 Thus, we interrogated the hypothalamus for molecular changes induced by Gly-Low.”
Yang, Y., Chen, L., Zhang, Y., Fu, W., Liu, D., & Jiang, T. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1607443 · Cited by 7
The role of GLP-1 receptor in pain disorders and its pharmacological properties
Jing, F., Zeng, Y., Yu, Q.-L., & Fu, C. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178345 · Cited by 6
Zhou, M., Du, M., Tang, R., Liu, H., Gao, Z., Wang, Y., You, H., Hao, J.-W., Ji, Z., Wang, D., et al. (2023) · Neuroendocrinology · doi:10.1159/000529438 · Cited by 5
Yoo, S., Yoo, E.-S., Kim, J. I., & Sohn, J. (2025) · Endocrinology and Metabolism · doi:10.3803/enm.2024.2185 · Cited by 4
Singh, I., Wang, L., Xia, B., Liu, J., Tahiri, A., Ouaamari, A. E., Wheeler, M. B., & Pang, Z. P. (2022) · Research Square · doi:10.21203/rs.3.rs-1971723/v1 · Cited by 4
Self-citationGLP-1 Receptor Agonists at the Crossroads of Circadian Biology, Sleep, and Metabolic Disease
Gandhi, A., Phyu, E. M., Koom‐Dadzie, K., Dickson, K. B., & Halm, J. K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062853 · Cited by 6
“…GLP-1 receptors in the dorsomedial hypothalamus and related hypothalamic nuclei, incretin signaling helps align feeding behavior with the master clock, as disruption of this pathway abolishes normal diurnal feeding patterns and blunts meal-induced activation of the suprachiasmatic nucleus [69,73].”
Long, Y., Xu, J., Xu, Z., Su, Z., Li, W., & Li, J. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119692 · Cited by 3
Self-citationBaumer-Harrison, C., Graham, M., Jonghe, B. C. D., & Hayes, M. R. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.06.015 · Cited by 8
Zhong, K., Xiang, L., Wan, Y., & Zhou, Y. (2024) · Neurological Sciences and Neurophysiology · doi:10.4103/nsn.nsn_150_23 · Cited by 3
Xu, Z., Wen, S., Dong, M., & Zhou, L. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16146 · Cited by 4
“…dense concentrations of GLP-1 neuronal fibres, we propose that GLP-1R signal transduction in the DMH may be essential for the regulation of the SNS. 49 Other research has indicated that the stimulation of GLP-1R in the DMH results in a substantial increase in BAT thermogenesis, despite the absence…”
InfluentialSelf-citationGPCRs in hypothalamic neurons and their roles in controlling food intake and metabolism
Qiu, T., & Fu, O. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1536577 · Cited by 4
Wei, J., Wu, H., Zheng, Y., Wang, N., Benedict, C., Chen, W., & Tan, X. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111927 · Cited by 3
“…that underlie these associations are not well understood, GLP-1 signaling in the arcuate nucleus and dorsomedial hypothalamic nucleus, located in the hypothalamus, has been recognized as a key part of the central nervous GLP-1 system, playing a vital role in improving glucose homeostasis [31 – 33].”
Ding, H., Wang, M., Zhang, J., Wan, C., Huang, Z., Liu, L., & Liu, J. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00174.2025 · Cited by 5
Self-citationMechanisms of glucagon-like-peptide 1 in the brain beyond metabolic effects
Kim, K. S., Park, J. S., & Choi, H. J. (2025) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2448320.160 · Cited by 3
“Indeed, GLP-1 was able to change synaptic plasticity in the PVH [46], hippocampus [47], LS [48], and the DMH [49,50].”
Soedono, S., Vo, D. H. N., Chang, J., Sharlene, S., Bayona, P. W., Kim, S., Hong, J. Y., & Cho, K. W. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.10.032 · Cited by 1
“Beyond pancreatic function, GLP-1R signaling in the central nervous system (CNS) plays a crucial role in energy balance and glucose metabolism [48].”
Yao, T. S., Wu, G., Zeng, Y., Xie, Y., Cui, X., Zhang, Q., Yan, C., Cui, Z., Gong, H., Tianze, X., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102616 · Cited by 2
“48,49 Such selective activity underscores LW6’s therapeutic promise, as it may normalize pathological hyperglycemia in obesity, prediabetes, or T2D without risking hypoglycemia in normoglycemic states.”
Mekki, Y. M., Park, J., Alzaareer, Z., Hussain, Z., Gulzar, A., Elzouki, A. Y. A., Güemes, A., & Zughaier, S. M. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01876-w · Cited by 1
“The brainstem also conveys signals of metabolic states to the arcuate nucleus of the hypothalamus via the nucleus tractus solitarius (NTS) [56, 65, 66], which picks up humoral factors like glucose-like peptide 1 (GLP-1), ghrelin, and cholecystokinin (CCK) [67–71].”
Vagal GABAergic signaling in autonomic control of cardiometabolic function
Boychuk, C. R., & Wang, Y. B. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00790.2025 · Cited by 2
Exendin-4 enhances GLP-1 signaling and reduces anxiety-like behaviors in male heroin withdrawal mice
Xiang, Y., Yan, X., Li, R.-R., Li, C., Yin, D., Luo, C.-C., Xiong, Y.-Q., Hong, Y., Li, Y.-X., & Xia, B.-J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0343995 · Cited by 1
“To elucidate the neural pathways associated with GLP-1, we employed the retrograde tracing virus pAAV-hSyn-EGFP-2A-Cre-WPRE in the BLA region of the brain [6,20,54] (Fig 4A-B).”
The central amygdala gates exogenous glucagon-like peptide 1 signals
Duran, M., Zeng, N., Cutts, E. J., POLAMARASETTY, A., Rodríguez, M., Habegger, K. M., & Hardaway, J. A. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102403 · Cited by 2
Huang, Y., Liu, K.-W., Li, P., Chen, J.-C., Meyerowitz‐Katz, G., Su, P., & Huang, C. (2026) · Communications Medicine · doi:10.1038/s43856-026-01750-z · Cited by 3
“…favored tirzepatide for anxiety disorder and insomnia, whereas the corresponding hazard ratios favored semaglutide (anxiety HR 1.12, 95% CI 1.06 – 1.18; insomnia HR 1.13, 95% CI 1.05 – 1.21); this direction reversal re fl ects how absolute and relative measures integrate event timing differently…”
InfluentialSanetra, A. M., Palus‐Chramiec, K., Chrobok, Ł., Jeczmien‐Lazur, J. S., Klich, J. D., & Lewandowski, M. H. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103873 · Cited by 3
“In line with previous reports (Merchenthaler et al., 1999; Tang-Christensen et al., 2000, 2001; Cork et al., 2015; Lee et al., 2018; Maejima et al., 2021; Huang et al., 2022), we observed fluorescent signal from both Glp1r-and Glp2r -targeting probes within the DMH.”
InfluentialBellucci, A., Alfares, H., Gale, C., Akcan, M., Waters, B., Eisner, K., Baranowski, B. J., Jeromson, S., Babicki-Moore, A., & Wright, D. C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.21.727027 · Cited by 1
Hypothalamus-Sympathetic-Liver Axis Mediates the Early Phase of Stress-Induced HyperglycemiaPreprint
Liu, L., Huang, Z., Zhang, J., Wang, M., Wu, Y., Zhang, Z., Bi, G., & Liu, J. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4510515
Self-citationKrishnan, G., Bagath, M., Devaraj, C., & Soren, N. M. (2024) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2024.114602
Satué, K., Fauci, D. L., Medica, P., Velasco-Martínez, M. G., Cravana, C., Bruschetta, G., & Fazio, E. (2025) · Stresses · doi:10.3390/stresses5010004
“The hypothalamus is an important metabolic center for the regulation of “gut–brain” activity and has been well characterized in GLU metabolism [17,18,22–24].”
The emerging role of epsilon cells in glucose homeostasis and lipostasis
Pavithra, N., Singh, S. A., Begum, R. F., Undela, K., Nirenjen, S., Keerthana, B., Singh, A., Mageswari, R., & Sabarathinam, S. (2025) · Obesity Medicine · doi:10.1016/j.obmed.2025.100672
Zhang, S., Suo, M., Yi, Z., Fu, P., Zhang, C., Yue, C., Li, J., Zeng, Y., & Chen, Y. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106583 · Cited by 3
Recent progress in understanding hypothalamic regulation of energy homeostasis
ZHANG, Z., Yu, Z. E. N. G., Cui, Z., & TieMin, L. I. U. (2026) · Scientia Sinica Vitae · doi:10.1360/ssv-2025-0283
Hypothalamus-liver talks: whispers in the language of metabolism
Ferreira, V., Fernández-González, I., Vattathara, J. J., Rodríguez-Díaz, A., Fernández-Sanmartín, P., & Diéguez, C. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10031-y
“Liver sensory neurons are responsible for sending feed-back to the hypothalamus, mainly to the ARC and VMH, on the metabolic state of the liver and, as a proxy, of the whole organism (e.g., glucose, lipid and amino acid levels) [ 19 , 26].”
The central amygdala integrates exogenous glucagon-like peptide 1 signalsPreprint
Duran, M., Zeng, N., Cutts, E. J., Habegger, K. M., & Hardaway, J. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.06.716705
“…GLP-1R-expressing cells within the CNS and their effects on physiology and behavior [3], [4], [5], [6], [7], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38],…”
Fang, H., Liu, A., Yang, J., Liu, M., Zheng, Y.-Y., Zhang, H., Guo, J.-R., Luo, P.-P., Yang, D.-S., Wang, R., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03870-8
“These neurons project to the pancreas via brainstem vagal pathways, and activation of this neural circuit enhances insulin secretion, leading to blood glucose reduction [75, 80, 81].”
Cyclic neuronostatin regulates glucose homeostasis and food intake through GPR107 phosphorylation
Yang, S., Zhang, Y., Li, M., Li, Y. A., Guo, Y., Li, Y. A., & Shao, T. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111026
Bellucci, A., Alfares, H., Gale, C., Akcan, M., Waters, B., Eisner, K., Baranowski, B. J., Jeromson, S., Babicki-Moore, A., & Wright, D. C. (2026) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00220.2026
Cephalic phase response in systemic glucose metabolism: How taste triggers glucose homeostasis
Li, C., Ngurari, S., Ye, J. J., & Toda, C. (2026) · Journal of Oral Biosciences · doi:10.1016/j.job.2026.100813
The impact of obesity on appetite regulation during nutritional ketosis
Grabowski, M., Grabowska, K., Nowacka-Chmielewska, M. M., Małecki, A., Jędrzejowska–Szypułka, H., Barski, J. J., & Liśkiewicz, D. (2026) · Scientific Reports · doi:10.1038/s41598-026-71103-2
Brain-body crosstalk in T2DM: An integrative framework from central sensing to peripheral feedback
Zhang, Y., Zhang, X., Fang, X., Zhao, X., Xiao, C., Fan, M., Zhang, Y., & Liu, Z. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106975
GLP-1 receptor biology and the therapeutic role of incretin-based agonists in metabolic diseases
Koceva, E., & Moll, G. N. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179406
Metadata
- Authors
- Huang, Z., Liu, L., Zhang, J., Conde, K., Phansalkar, J., Li, Z., Yao, L., Xu, Z., Wang, W., Zhou, J., Bi, G., Wu, F., Seeley, R. J., Scott, M. M., Zhan, C., Pang, Z. P., & Liu, J.
- Affiliations
- University of Science and Technology of China (CN)
- Rutgers, The State University of New Jersey (US)
- CAS Key Laboratory of Brain Function and Diseases, Life Science School, University of Science and Technology of China, Anhui, China.
- Institute of Artificial Intelligence, Hefei Comprehensive National Science Center, Hefei, China.
- University of Michigan (US)
- University of Virginia (US)
- Corresponding author
- Huang, Zhaohuan
- Liu, Ling
- Zhang, Jian
- Liu, Ji
- ORCID
- Venue
- Science Advances
- Published
- 2022-06-10
- Volume
- 8
- Issue
- 23
- Pages
- eabn5345-eabn5345
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC9177072
- OpenAlex
- W4282930998
- Cited by
- 78
- References
- 57
- Citations by year
- 2026: 22 · 2025: 23 · 2024: 15 · 2023: 14 · 2022: 4
- FWCI
- 7.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R01MH116694)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK020572)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- glucagon-like peptide-1, GLP-1 receptor, dorsomedial hypothalamus, glucose detection, blood glucose regulation, energy homeostasis, dorsal motor nucleus of the vagus, insulin secretion, cAMP/PKA signaling, delayed rectifier potassium current
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Blood Glucose, Glucose, Hypothalamus, Neurons, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.